Stereotactic Body Radiation Therapy Clinical Trials
38 recruitingRadiation
Phase 216Not Applicable9Phase 18Phase 36
Showing 1–20 of 38 trials
Recruiting
Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Stage III Prostate Cancer AJCC v8Prostate AdenocarcinomaStage IVA Prostate Cancer AJCC v8
NRG Oncology1,209 enrolled398 locationsNCT05946213
Recruiting
Phase 3
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Stage III Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8Advanced Hepatocellular Carcinoma
NRG Oncology226 enrolled107 locationsNCT07166406
Recruiting
Phase 3
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8
NRG Oncology474 enrolled471 locationsNCT05624996
Recruiting
Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Metastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8Biochemically Recurrent Prostate Carcinoma+1 more
ECOG-ACRIN Cancer Research Group804 enrolled303 locationsNCT04423211
Recruiting
Phase 2
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Prostate CancerProstate AdenocarcinomaProstatic Neoplasms
National Cancer Institute (NCI)42 enrolled1 locationNCT05616650
Recruiting
Phase 1
Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
Metastatic Head and Neck Squamous Cell CarcinomaRefractory Head and Neck Squamous Cell CarcinomaLocally Recurrent Head and Neck Squamous Cell Carcinoma
University of California, Davis24 enrolled2 locationsNCT06211335
Recruiting
Phase 1
PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.
Advanced Prostate Cancer
M.D. Anderson Cancer Center70 enrolled1 locationNCT06369246
Recruiting
Phase 1
Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.
Digestive System Neuroendocrine TumorUnresectable Digestive System Neuroendocrine NeoplasmUnresectable Digestive System Neuroendocrine Tumor G1+1 more
Emory University15 enrolled2 locationsNCT07150546
Recruiting
Phase 1
Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)
Metastatic Malignant Solid NeoplasmLymphoma
City of Hope Medical Center10 enrolled1 locationNCT05371132
Recruiting
Phase 1
Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC
Locally Advanced Skin Squamous Cell CarcinomaUnresectable Skin Squamous Cell CarcinomaResectable Skin Squamous Cell Carcinoma
City of Hope Medical Center12 enrolled1 locationNCT05085496
Recruiting
Not Applicable
Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
Lung CarcinomaMetastatic Malignant Neoplasm in the LungMalignant Respiratory Tract Neoplasm
M.D. Anderson Cancer Center30 enrolled1 locationNCT03422302
Recruiting
Not Applicable
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
Anatomic Stage 0 Breast Cancer AJCC v8Invasive Breast CarcinomaAnatomic Stage 1 Breast Cancer AJCC v8+3 more
Thomas Jefferson University80 enrolled1 locationNCT04959474
Recruiting
Phase 3
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Stage III Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8Biochemically Recurrent Prostate Carcinoma+4 more
Mayo Clinic118 enrolled6 locationsNCT06205316
Recruiting
Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
Stage IVB Prostate Cancer AJCC v8Prostate AdenocarcinomaOligometastatic Prostate Carcinoma+2 more
NRG Oncology194 enrolled239 locationsNCT05053152
Recruiting
Phase 3
Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases, PREEMPT Trial
Metastatic Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone
NRG Oncology280 enrolled576 locationsNCT06745024
Recruiting
Phase 2
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Malignant Solid NeoplasmMelanomaRenal Cell Carcinoma+1 more
City of Hope Medical Center32 enrolled1 locationNCT05830058
Recruiting
Phase 2
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Biochemically Recurrent Prostate CarcinomaRecurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate Cancer+1 more
Mayo Clinic532 enrolled3 locationsNCT06378866
Recruiting
Phase 2
Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma
Recurrent Prostate AdenocarcinomaOligometastatic Prostate Adenocarcinoma
Jonsson Comprehensive Cancer Center107 enrolled1 locationNCT07150715
Recruiting
Phase 2
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
Metastatic Renal Cell CarcinomaRenal Cell CarcinomaOligoprogressive+1 more
Yale University30 enrolled1 locationNCT04974671
Recruiting
Phase 1Phase 2
Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer
Solid Tumor, AdultOligometastatic Disease
Gustave Roussy, Cancer Campus, Grand Paris58 enrolled2 locationsNCT06439888